ArticlemAbs

Inhibition of insulin receptor function by a human, allosteric monoclonal antibody: a potential new approach for the treatment of hyperinsulinemic hypoglycemia.

John A Corbin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.